Salivary Gland Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-07-06
Clinical Trial Update: A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma [Phase 2]
Phase 2 study evaluating apalutamide in combination with a GnRH agonist for androgen receptor-positive salivary gland carcinoma; results wer…